Transgenic Group Inc. (TYO:2342)

Japan flag Japan · Delayed Price · Currency is JPY
289.00
-1.00 (-0.34%)
At close: Mar 6, 2026
Market Cap4.81B +59.7%
Revenue (ttm)12.89B -1.9%
Net Income-770.00M
EPS-46.24
Shares Out16.65M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume90,700
Average Volume461,450
Open288.00
Previous Close290.00
Day's Range283.00 - 293.00
52-Week Range130.00 - 487.00
Beta0.28
RSI47.25
Earnings DateFeb 10, 2026

About Transgenic Group

Transgenic Group Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through Drug Discovery Support Business and Investment and Consulting Business segments. The company provides glycan synthesis and analysis services; non-clinical studies for pharmaceuticals, foods, cosmetics, chemical substances, etc., as well as various safety tests for foods, and pharmaceutical agents; and support for bioequivalence test, including clinical trials, pharmacokinetic measurements, and the preparation of cl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 241
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2342
Full Company Profile

Financial Performance

Financial Statements